LRG1, CLU, F2, SERPIND1, A2M, SERPINF2, SERPINA1, CFB, and C3 were identified as candidate biomarkers for early diagnosis of B-ALL; all were over-expressed in the B-ALL group compared to the control and AIT groups. The gene discussed is SERPIND1; the disease is acute lymphoblastic leukemia.